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ABSTRACT
Proteomic Evaluation and Cytotoxicity of Red Maple (Acer rubrum) Leaves
by Saud O. Alshammari

Red maple (Acer rubrum), also known as swamp, water or soft maple, is endemic to eastern
and central North America and was widely used as traditional medicine by the first peoples.
Commercially, its well-known products include maple syrup and high-quality lumber. The
potential medicinal benefits of phenolic compounds extracted from the red maple plant,
such as glucitol-core containing gallotannins, include antioxidant, and antiglycation effects
as well as their importance in cosmetic applications. Plant-derived proteins and peptides
are important biomolecules; however to date, there is no published data on the
identification of proteins/peptides from red maple leaves. Therefore, the present study
focuses on the activity guided purification of proteins from red maple leaves collected in
spring and fall seasons. In addition, the focus of this project was in the evaluation of maple
leaves employing bottom-up proteomics and De Novo protein profiling by PEAKS StudioX and Gene Ontology Bioinformatics. The red maple leaves were grounded, defatted in
hexane and proteins extracted in 25 mM sodium phosphate buffer pH 6.5. The extracted
crude proteins were recovered by precipitation in 80% ammonium sulfate. The firstdimensional chromatography of crude extracted proteins was performed on a gel filtration
column (HiLoad 16/600 Superdex200). The separation of crude extract and the partially
purified gel filtration fraction was conducted by reversed-phase HPLC. The crude and
eluted fractions were analyzed by SDS-PAGE gel electrophoresis. The extract was
screened for cytotoxicity activity on Michigan Cancer Foundation-7 breast cancer (MCF7), M.D. Anderson Metastasis Breast (MDA-MB-231) cancer cell lines and anti-
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inflammatory activity on murine macrophage (RAW 264.7) cell line from American Type
Culture Collection (ATCC). The drug Doxorubicin was used as a positive control whereas
untreated cells as a negative control in these experiments Preliminary data revealed that
active protein fractions were eluted at two different regions of gel filtration
chromatography both in spring and fall leaves. Bottom-up proteomics of crude and active
fractions by PEAKS Studio-X and MASCOT bioinformatics database identified over 54
proteins. The Gene Ontology Annotation classified these proteins involved in the
biological processing, cellular compartment, and molecular functions.
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Chapter 1
INTRODUCTION
1.1. Herbal Medicine
An herb refers to a plant or any part of a plant such as leaves, flower, bark, seeds, and fruit that is
used for its medicinal, aromatic, or flavoring properties. Herbal medicine is the use of unpurified
plant extracts or plant components for their therapeutic activity (Kunle et al., 2012). Many
civilizations have used the plants for their medicinal benefits such as Egyptian, Chinese, Greek,
Indian, and Mediterranean for over 4,000 years as remedies for various ailments. In the 19th
century, medicinal plants led to the start of a new era of discovery, substantiation, and isolation of
many plant-based herbal medicines such as alkaloids from poppy, ipecacuanha, strychnos, quinine,
and pomegranate. However, scientific pharmacy began with the isolation of glycosides. Later, the
advanced techniques have facilitated discoveries of new substances from the medicinal plants,
such as tannins, saponosides, etheric oils, vitamins, and hormones (Petrovska, 2012).

1.2. Importance of Herbal Medicine
The herbal remedies are used for more than 80% of various diseases in the population of
developing countries (WHO, 2003). In the underdeveloped countries, many people used herbal
medicine because of limited access to advance medicine as well as poverty (Kunle et al., 2012).
Whereas, the developed countries, the emphasis is on the discovery of pharmacologically active
chemical entities which limited the uses of traditional herbal medicine in healthcare (Pirottaet al.,
2000; Suchardet al., 2004). However, in the past few years, there is tremendous growth in the
global demand for herbal products as supplements. According to the recent report (March 27,
2019) by Market Watch (https://www.marketwatch.com/press-release/herbal-supplements-
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market-2019-global-analysis-share-trends-application-analysis-and-forecast-to-2024-2019-0327), there is a tremendous growth in global herbal supplements market accounted for $49.1 billion
in 2016 and forecasted to reach about $86.7 billion by 2022 with the compound annual growth rate
of 9.9% from 2016 to 2022.

1.3. Herbal Medicine in Cancer Therapy
Cancer is one of the major diseases that cause an increase in mortality in the world population.
According to the National Center for Health Statistics in 2019, the number of deaths from cancer
estimated as 606,880 and 1,762,450 as new cases in the United States (Siegel et al., 2019).
Conventional medicine of cancer, such as surgery, chemotherapy, and radiotherapy is the primary
methods to treat cancers.

Plant-derived natural products have been in use for several years. Many of these approved anticancer agents isolated from plants (Dholwani et al., 2008). Some of the key plants derived natural
products approved as anti-tumor agents in the USA are Vinblastine, Vincristine, Taxol, and
Camptothecin (Demain & Vaishnav, 2011). Vinblastine and vincristine are alkaloids from the
Madagascar periwinkle plant (Catharanthus roseus). Herbal formulations are typically used in
Chinese medicine. According to Chinese herbal clinicians, the herbal formulations, such as
PHY906 (KD018) and flavonoids derived from Scutellaria baicalensis are affecting cancer in
multiple ways: (1) Protecting body normal cells and tissues from the side effects of
chemo/radiotherapy; (2) maximizing the effect of chemo/radiotherapy; (3) minimizing infectious
and inflammatory complications in tissues located around carcinoma; (4) enhancing body
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resistance and immunity; (5) improving the patient quality of life and prolonging life span (Hsiao
& Liu, 2010).

According to the GLOBOCAN 2012 report, colorectal cancer is the third most common reason for
death by cancer diseases (Ferlay et al., 2015). One novel peptide called BG-4 was isolated, purified,
and characterized from Momordica charantia plant has shown activity against HCT-116 and HT29 human colon cancer cells as shown by trypsin inhibitor assay (Dia & Krishnan, 2016). Also,
another protein extracted from the leaves of Morinda pubescens has shown cytotoxic activity
against A549 human cancer cell line (Thomas et al., 2017). In another study, proteins extracted
from Gynura procumbens showed anti-cancer activity in breast cancer cell line, MDA-MB-231 as
shown by lactate dehydrogenase (LDH) cytotoxicity assay (Hew et al.,2013). This information
revealed the significant role of extracted bioactive proteins and peptides in the treatment of several
cancer conditions (Hernández et al., 2013).

1.4. Herbal Cosmeceuticals
However, nowadays the herbal products not only used as remedies but also used for cosmetic
purposes. With that increase in demand for plant resources as cosmetics, the cosmetics industry is
focusing now on traditional herbal cosmetic knowledge. It is becoming an essential resource for
economic development and innovation (Evariste et al., 2017). In the 1990s, the pharmaceutical
company began to use the term cosmeceuticals for any pharmaceutical products that intended to
enhance the beauty and health (Vasisht & Kumar, 2002). Also, R.E Reed, in 1962, defined the
cosmeceutical term in four points. (1) A cosmeceutical is a scientifically designed product intended
for external application to the human body (2) A cosmeceutical produces a useful, desired result
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(3) A cosmeceutical has desirable aesthetic properties; and (4) A cosmeceutical meets rigid
chemical, physical and medical standards (Reed, 1964). The cosmetics industry has discovered
many plants as sources of innovative ingredients with specific pharmacological properties such as
anti-inflammatory,

anti-allergy,

anti-carcinogenic,

moisturizing,

anti-aging,

and

anti-

hyperpigmentation (Dorni et al., 2017).

1.5. Red Maple (Acer rubrum)
The red maple, also known as swamp, water, or soft maple, is located in eastern North America,
as shown in Figure 1. The people of eastern North American region use it as an herbal medicine
for multiple conditions, including diarrhea, abdominal pain, eye diseases, and several skin
disorders (Lans et al., 2007). Recently, researchers from the University of Rhode Island
investigated the phytochemical products extracted from red maple leaves for medical purposes and
cosmetic applications. A new gallotannin were isolated from red maple leaves have shown a potent
α-glucosidase inhibitory effect. Also, the gallotannin are active against melanin overproduction in
B16F10 cells. The accumulation of abnormal melanin may cause several skin hyperpigmentation
disorders, such as freckles, age spots, post-inflammatory hyperpigmentation, as well as melanoma.
The MaplifaTM is a new product that extracted from red maple leaves which contains 40–45%
ginnalin A (GA) and other phenolic compounds. GA decreases the levels of reactive oxygen
species (ROS) and melanin content in B16F10 melanoma cells, which means the GA can inhibit
the formation of glycation end products (AGEs) (Ma et al., 2017).
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Figure 1. Picture of Red maple leaves and its distribution in North America. Photos retrieved from
https://en.wikipedia.org/wiki/Acer_rubrum

Nevertheless, there are no studies conducted on the proteins and peptides extracted from red maple
leaves. Therefore, this collaborative research focused on the proteins and peptides of Red maple
leaves. The processes including isolation, purification, and characterization of proteins and
peptides employing bottom-up proteomics. Furthermore, to a better understanding of their
biological effects and therapeutic applications, cell-based anticancer assays were conducted using
MCF7, MDA-MB-231 cell lines. Whereas the anti-inflammatory assay was conducted on murine
macrophage (RAW 264.7) cell line.
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1.6. Proteomics
In 1995, proteome term was used for the first time by Marc R. Wilkins to describe the complement
of a protein genome (Wasinger et al., 1995). The proteome first book was published in 1997
(Wilkins et al., 1997). Leigh Anderson defined proteomics as “the use of quantitative protein-level
measurements of gene expression to characterize biological processes (e.g., disease processes and
drug effects) and decipher the mechanisms of gene expression control” (Anderson & Anderson,
1998). The significant role of proteins as direct bio-functional molecules in the living organisms
spark the ambition of the researchers and scientists to discover and investigate their therapeutic
effects for several diseases.

The advanced technologies, such as mass spectrometry and bioinformatics data analysis, promoted
the progress of in the isolation and characterization of peptides/proteins from various plants. The
bottom-up proteomics is the analysis of a mixture of peptides, derived from proteolytic digestion
of intact proteins by LC-MS/MS. To identify the peptide tandem mass spectra and match it with
theoretical tandem mass spectra that have been generated from in silico digestion of protein
databases, including PeptideMass and PeptideCutter at ExPASy, MS-Digest at Protein Prospector,
and Protein Digest at ISB. Also, the theoretical molecular weights and functional annotations of
the proteins can be determined by using Gene Ontology (GO) terms (Lu et al., 2008; Y. Zhang et
al., 2013). On the other hand, a different approach called ‘top-down’ proteomics, which performed
to characterize the intact proteins. This method has some advantages for post-translational
modifications (PTM) as well as protein isoform identification. Furthermore, top-down is useful to
characterize protein up to 200 kDa (Han et al., 2006), but it has critical limitations that represent
difficulties in protein fractionation, ionization, and fragmentation in the gas phase.
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In proteomics, a new technique named De novo sequencing now can be performed using
bioinformatics software package, PEAKS Studio-X. It is used in the characterization of the amino
acid sequence, which is not present in available protein sequence databases (NCBI and ExPASy).
This advance bioinformatics software uses a new algorithm model to obtain the best tryptic
fragmented peptide sequence ions from the interpretation of the peaks in the LC-MS/MS
quadrupole‐time‐of‐flight (Q-TOF) spectrum. The result of the PEAKS software gives the
identified amino acid sequences a confidence scores to each sequence to validate the results called
false discovery rate (FDR). The FDR is used to measure the accuracy of the outcomes to obtain
the percentage of the false identifications above the score threshold (Zhang et al., 2012).
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Chapter 2
METHODS
2.1. Materials
All chemicals used in this project were purchased from Thermo-Scientific, Bio-Rad, SigmaAldrich, or Acros. The reagents and biological materials include sodium phosphate dibasic and
monobasic, hexane, Tris (hydroxymethyl) aminomethane, hydrochloric acid (HCl, 37%),
ammonium sulfate, acetic acid, trifluoroacetic acid (TFA), acetonitrile (ACN). ammonium
persulfate (APS), acrylamide, N,N,N’,N’-tetramethylethylenediamine (TEMED), bisacrylamide,
urea, glycerol, 2-mercaptoethanol, brilliant blue G-pure, 10x Tris/Tricine/SDS, sodium dodecyl
sulfate (SDS), trypsin, tosyl-phenylalanyl-chloromethyl-ketone (TPCK) treated, dithiothreitol
(DTT), iodoacetamide, phosphate-buffered saline (PBS), bovine serum albumin (BSA). trypan
blue, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide (MTT), fetal bovine serum
(FBS), 1% penicillin-streptomycin, Dulbecco’s Modified Eagle Medium (DMEM), dimethyl
sulfoxide (DMSO), doxorubicin hydrochloride. Hiload 16/600 Superdex 200 pg column, Vydac
C18 (2.1x150mm) column. Dialysis tubing (3500 D MWCO), Amicon® ultra centrifugal filters
(3000 D MWCO). MDA-MB-231 (ATCC® HTB-26™) and MCF-7 (ATCC® HTB-22™).

2.2. Protein Extraction
Fall and Spring Red maple leaves were collected from Rhode Island in the United States. Leaves
were immersed in n-hexanes for 24 hr separately. Hexane was removed by filter paper, and the
solid mass recovered dried at room temperature for 2 days in the chemical hood. Dried defatted
leaves were blended within three different conditions: i. 20 mM Tris/HCl pH 8, ii. deionized water,
and iii. 25 mM sodium phosphate pH 6.5 buffers and stirred for 4 days at 4℃. The samples were
filtered through cheesecloth. The recovered filtrate was centrifuged at 14,000 rpm using Thermo
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Scientific™ Sorvall LYNX 4000 Superspeed Centrifuge for 30 min. The supernatant collected and
precipitated with 80% ammonium sulfate at 4℃ and stirred for 24 h. Precipitated proteins were
recovered by centrifugation at 14,000 rpm for 10 min. The pelleted proteins were dissolved in
deionized water and dialyzed by using dialysis tubing (MWCO 3.5 kD) for 2 days at 4℃. The
dialyzed samples were lyophilized by using lyophilizer (Domżalska et al., 2016). The samples
were stored at 4℃ for further experiments. The schematic workflow adopted in this project is
presented in Figure 2.
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Protein Extraction
• Tris/HCl pH 8
• DI H2O
• Phosphate pH 6.5

Protein Precipitation
• Ammonium Sulfate

Protein Purification
• Gel Filtration
• RP-HPLC

Biological Assays
In-Solution Digestion

• Cytotoxic assay
• Anti-Inflammatory assay

Protein Characterization
• LC-MS/MS Q-TOF
• bioinformatics
• Mascot
• De novo sequencing (PEAKS)

Gene Ontology
Annotation

Figure 2. Schematic of workflow of Red maple leaves proteomics project.
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2.3. Gel Filtration Chromatography
The crude extracted proteins from both seasons (spring and fall) leaves were fractionated by using
ÄKTAStart (GE Healthcare) fast protein liquid chromatography (FPLC). The system is equipped
with a 280 nm detector and an automated fraction collector. The dried crude proteins were
dissolved in the same extraction buffer and loaded into the column. The gel filtration column
HiLoadTM 16/600 SuperdexTM 200 pg was pre-equilibrated with sodium phosphate pH 6.5, and the
sample was eluted in isocratic mode at 1 mL/min flow rate. The absorbance was monitored at 280
nm.

2.4. Reverse Phase High-Performance Liquid Chromatography (RP-HPLC)
The purification process was continued to purify proteins and peptides from red maple leaves by
using the RP-HPLC technique. The Hitachi Elite LaChrom HPLC system equipped with pump L2130, Diode Array Detector L-2455, Refrigerated auto-sampler L-2200, and software package
EZChrom Elite (version 3.3.2 SP2) was used. The crude proteins extracted in three different
buffers from different seasons (spring and fall) leaves were loaded onto a reversed-phase column.
The column Vydac C18 (2.1x150mm) equilibrated in 0.1% TFA-water. The samples were eluted
by a gradient 0-60% B (0.1% acetonitrile) in 85 min at 1 mL/min flow rate and absorbance at 280
nm.

2.5. Electrophoresis
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed for the
spring and fall crude proteins, as well as FPLC separated protein fractions. The tris/tricine SDSPAGE technique was used (Schägger & Jagow, 1987). The 10% separating gel and 4% stacking
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gel were prepared as listed in Table 1. The separating gel solution was poured in gel cassette, and
then, bubbles were removed by the spraying of 70% ethanol on the top of the separating gel and
waited for 20-30 minutes until the gel polymerized. The stacking gel was prepared, and before the
addition of stacking gel, ethanol was removed. The comb was placed immediately before stacking
gel polymerization. The samples were prepared by mixing 50% of protein and 50% tricine loading
buffer containing 2% of 2 β-Mercaptoethanol, and boiled at 95°C for 10 min. The samples at 10,
20, and 30 μL were loaded into the stacking gel and 10 μL of standard protein (ladder). The gel
was separated under electrical current of 200 V for 55 minutes using the 1x-Tris/tricine/SDS
running buffer. BioSafeTM Coomassie solution was used to stain the gel for 2 hr and then destined
using water overnight. Gels were imaged using ChemiDocTM Imaging system (Bio-Rad).

Table 1. List of gel casting solution for 10% separating and 4% stacking gels.
Gel Casting Solution
10% Separating gel 4% Stacking gel
40% Acrylamide/Bis (29:1)

3.75 mL

400 µL

Water

3.75 mL

775 µL

3 M Tris/HCl pH 8.45 containing

2.62 mL

1950 µL

50% Glycerol

1.125 mL

N/A

TEMED

15 µL

10 µL

30% APS

15 µL

10 µL

0.3% SDS
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2.6. Bottom-up Proteomics
The shotgun proteomics approach, which refers to bottom-up proteomics too, used to characterize
in-solution tryptic digest of crude maple leaves and FPLC fraction 14 (F14). The mass
spectrometer was equipped with Q-TOF Model Impact II (Bruker) connected to the UltiMate 3000
UHPLC Systems (Thermo-Fisher Scientific).

2.6.1. In-Solution Digestion
The lyophilized fall crude maple leaves proteins 40 mg and lyophilized active fraction F14, were
solubilized in 400 µL of 6M urea prepared in 50 mM tris and mixed with 20 µL of reducing agent
200 mM dithiothreitol (DTT). The 200 mM DTT was prepared in 50mM Tris pH 8.0. The samples
were vortexed and incubated for 1 hr at room temperature. Then, 80 µL (200 mM) of the alkylating
agent iodoacetamide was added to the mixtures and incubated in the dark for 1 hr at room
temperature. The iodoacetamide 200 mM was prepared in 50mM Tris pH 8.0. After Iodoacetamide
was added, 80 µL of DTT was mixed with the samples again and incubated for 30 min at room
temperature. Then, the pH was monitored while adding 50mM Tris pH 8.0 until the pH adjusted
at 8.0. The trypsin was prepared in 50 mM tris/HCl pH 8.0 and was added in ratio 1:30
(Trypsin:Protein). The mixture was incubated overnight (<16 hr). On the next day, the digestion
was stopped by adding acetic acid until pH 4.0 reached.

2.6.2. LC-MS/MS Q-TOF
The tryptic digest of crude maple leaves proteins and fractions F14 were analyzed by using Impact
II™ UHR-QqTOF (Ultra-High Resolution Qq-Time-of-Flight) mass spectrometry instrument
along with Phenomenex BioZen 2.6 µm Peptide XB-C18 (pore size 100 Å, dimension 150×2.1)
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column. The mobile phase used was solvent A: 0.1% formic acid in water and solvent B: 0.1%
formic acid in ACN at a flow rate of 0.3 mL/min. The elution gradient was 0-55% B in 45 min.

2.6.3. MS/MS Data Analysis
In these experiments, Mascot and De novo sequencing by PEAKS bioinformatics software were
used. The data obtained from MS/MS called mascot generic files (mgf). These data were used to
search in SwissProt and NCBI nr- taxonomy Viridiplantae database. The search parameters
selected is illustrated in Table 2. Whereas, De novo sequencing PEAKS search parameters are
illustrated in Table 3.

Table 2. The parameters used in Mascot search.
Search Parameters
Fixed modification

Carbamidomethylation of cysteine

Variable modification

Oxidation of methionine

Peptide mass tolerance

± 1.2 Da

Fragment mass tolerance

± 0.6 Da

Enzyme

Trypsin

Max Missed Cleavages

1

The false discovery rate

1%

Probability

99% for the crude
95% for F14
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Table 3. The parameters used in De novo sequencing (PEAKS) search.
Search Parameters
Search Engine Name

PEAKS

Parent Mass Error Tolerance

50.0 ppm

Fragment Mass Error Tolerance

0.5 Da

Precursor Mass Search Type

Monoisotopic

Enzyme

Trypsin

Max Missed Cleavages

2

Digest Mode

Semi specific

Fixed Modifications

Carbamidomethylation: 57.02
Oxidation (M): 15.99
Acetylation (Protein N-term): 42.01

Variable Modifications

Pyro-glu from E: -18.01
Pyro-glu from Q: -17.03

Max Variable PTM Per Peptide

3

Database

Viridiplantae-reviewed

Taxon

All

FDR Estimation

Enabled

Merge Options

No merge

Precursor Options

Corrected

Charge Options

No correction

Filter Charge

2-6

Process

True

Associate chimera

Yes

De novo ALC Score

≥50%

Protein -10lgP

≥20
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2.6.4. Gene Ontology Annotation
In this search, the UniProt Knowledgebase (UniProtKB) gene ontology (GO) project was used to
obtain

the

annotation

of

gene

ontology

from

the

identified

proteins

(https://www.uniprot.org/uniprot/). The proteins were categorized based on their biological
process, molecular functions, and cellular compartment.

2.7. Cytotoxic Evaluation of Protein Extracts
2.7.1

Protein Estimation

The Coomassie (Bradford) protein assay kit (Thermo Scientific) was used for the estimation of
total protein concentration. PBS was used as a diluent for BSA standard as following
concentrations: 2,000, 1,500, 1,000, 750, 500, 250, 125, 25 µg/mL, and blank. The protein extracts
in sodium phosphate buffer were desalted and concentrated by centrifugal filters (3,000 Da
MWCO). Using 96-well plate, 2 µL of protein extract, and an equal amount of BSA were mixed
and added in triplicates. Then, 250 µL of Coomassie Plus Reagent solution was added to each
sample and incubated in the dark for 10 min. The samples were analyzed by using SpectraMax M5
UV/VIS Plate Reader to measure the absorbance at 595 nm. The concentration was obtained from
calculating the average reading of the triplicate results.

2.7.2. MTT Assay
The potential cytotoxic activity of the proteins extracted from red maple was evaluated by
performing MTT assay (Hansen et al.,1989). Human breast cancer MCF-7 (ATCC HTB-22TM)
and MDA-MB-231 (ATCC® HTB-26™) cell lines were cultured and maintained in DMEM
medium supplemented with 10% (v/v) of fetal bovine serum (FBS) and 1% (v/v) penicillin-
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streptomycin in a humidified incubator at 37ºC containing 5% CO2. The cells were cultured in
tissue culture treated flasks (T-75 flask) of 75 cm2 at confluency. After the medium was removed,
7 mL of PBS was used twice for cell washing. The cells were detached from the flask surface by
adding 1 mL of trypsin and incubated in a CO2 incubator at 37ºC for 3 min. Then 4 mL of the
medium was added, and cells were transferred into 15 mL tube. The cells were centrifuged at 1,000
rpm for 5 min. The supernatant was removed, and 1 mL of the medium was mixed with the pellet.
In cells counting process, trypan blue was mixed with 10 µL of the cell suspension and counted
the cells under a microscope by using hemocytometer. In order to prepare the cells for the treatment,
the cells were diluted at a density of 3x104/mL in 96 well plate in 200µl of volume (10,000 cells
in each well) and incubated in 5% CO2 incubator at 37ºC for 24 hr. The medium was removed
from the flask, and cells were treated at different concentrations of F14 (in triplicate). The
concentrations were used as following 4 µg/mL, 2 µg/mL, 1 µg/mL, 0.5 µg/mL, 0.25 µg/mL, 0.12
µg/mL, and 0.06 µg/mL. The negative control in this experiment was untreated cells, whereas the
positive control was doxorubicin in different concentrations as following 0.6 µM, 0.3 µM, 0.15
µM, 0.07 µM, and 0.03 µM. After 48 h, the medium containing the samples were removed, and
0.5 mg/mL of MTT dye was prepared in 200 µL medium was added to each well and incubated
for 4 h in 5% CO2 incubator at 37°C. The medium containing MTT dye was removed after
incubation, and the formazan crystals were solubilized in 100 µL of DMSO in each well. The
absorbance was measured at 550 nm using SpectraMax M5 UV/VIS Plate Reader. The percentage
of cell inhibition was calculated using the formula:
% 𝐼𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 =

𝑂𝐷 𝑜𝑓 𝑢𝑛𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑐𝑒𝑙𝑙𝑠 − 𝑂𝐷 𝑜𝑓 𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑐𝑒𝑙𝑙𝑠
𝑥100
𝑂𝐷 𝑜𝑓 𝑢𝑛𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑐𝑒𝑙𝑙𝑠
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2.8. Anti-Inflammatory Assay
The potential anti-inflammatory activity of the proteins extracts from Fall and Spring red maple
leaves were evaluated by performing the cell-based assay. In this experiment, RAW 264.7 Murine
Macrophages cell line was used at a density of 2.5x0000 and seeded in a 96-well plate and
incubated overnight. Next day, lipopolysaccharide (LPS) 1 µg/mL and 200 µg/mL of the protein
samples were added to cells and incubated for another 24 hr. The Nitric oxide (NO) production
was measured by using Griess Reagents. The NO production measures the anti-inflammatory
activity of the samples. If the cells produced less amount of NO, it means the protein samples
possess anti-inflammatory activity. The crude protein extracts from Fall and Spring were used, as
well as the Fall and Spring FPLC fractions (F12, F13, F14, F15, F19, and F20-21), (S4-8, S9-10,
S11-13, S14, and S15-18), respectively. The positive control in this assay was lipopolysaccharide
(LPS).
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Chapter 3
RESULTS AND DISCUSSION
3.1. Protein Extraction and Precipitation
Fatty acid removal process before the protein extraction was achieved by immersion of Fall and
Spring Red maple leaves in 100% hexanes for 24 hr. The protein extraction was performed in three
different buffers; 25 mM sodium phosphate pH 6.5, deionized water, and 20 mM Tris/HCl pH 8.0.
Proteins precipitation were successfully achieved using 80% ammonium sulfate. This technique is
preferred because the ammonium sulfate has properties such high solubility in aqueous buffers,
low density and relatively inexpensive as compared to other protein precipitation technique
employed organic solvent acetone or acidified acetone with 2% HCl. At the concentration of 60%,
ammonium sulfate extracted proteins recovered by precipitation based on “salting out”. The
denatured proteins are recovered can be pushed back into their native conformations. This step
helped to get rid of small molecules and non-protein soluble components from the extracts. The
extraction conducted in phosphate buffer resulted in comparatively more protein quantity than
deionized water and Tris/HCl, respectively.

3.2. Gel Filtration Chromatography
The partial purification of protein extracted from Red maple leaves was accomplished by using
gel filtration chromatography on HiLoadTM 16/600 SuperdexTM 200 pg column using ÄKTA start
FPLC system. This column was used as it has a wide protein separation range from 10-600 kD.
The gel filtration was used as the first-dimensional purification step which separates proteins based
on their molecular weight in elution order from high molecular weight to low molecular weight
proteins/peptides. The proteins extracted in 25 mM sodium phosphate pH 6.5, eluted into two
major peaks marked as F12-13 and F14-15. were observed in the separation profile of spring leaves

19

protein extract, as shown in Figure 3. In contrast, using the same chromatography conditions Fall
leaves extract separated into four major peaks, namely F12-13, F14, F19, F20-21as shown in
Figure 4.

F12-13

Absorbance 280 nm

F14-15

Volume (mL)

Figure 3. Gel filtration chromatography elution profile of crude protein from Red maple
spring leaves. Column: HiLoadTM 16/600 SuperdexTM 200 pg, buffer: 25 mM sodium
phosphate pH 6.5, flow rate at 1 mL/min, and absorbance at 280 nm.
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Absorbance 280 nm

F14

F20-21
F12-13

F19

Volume (mL)

Figure 4. Gel filtration chromatography elution profile of crude protein from Red maple fall
leaves. Column: HiLoadTM 16/600 SuperdexTM 200 pg, buffer: 25 mM sodium phosphate
pH 6.5, flow rate at 1 mL/min, and absorbance at 280 nm.
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3.3. Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC)
The RP-HPLC is most widely use chromatography technique for the separation of
proteins/peptides. It separate proteins based on their hydrophobicity properties from low to high
hydrophobicity. In this project, proteins extracted in three different conditions were evaluated by
RP-HPLC. The crude protein extracts from Spring and Fall were loaded onto a reversed-phase
column, Vydac C18 (2.1x150mm) column. The elution profiles showed that 25 mM sodium
phosphate pH 6.5 was the best extraction buffer, as compared to DI water and Tris/HCl, which
extracted comparatively more proteins from Red maple leaves. The elution profile observed using
all three extraction conditions for Spring and Fall leaves are shown as Figures 5-7.

Spring

Fall

Figure 5. RP-HPLC elution profile of Red maple crude proteins from Spring and Fall in 25 mM
sodium phosphate buffer. Column: Vydac C18 (2.1x150mm), gradient: 0-60% acetonitrile in 85 min,
flow rate 1 mL/min and absorbance at 280 nm.
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Spring

Fall

Figure 6. RP-HPLC elution profile of Red maple crude proteins from Spring and Fall in deionized
water buffer. Column: Vydac C18 (2.1x150mm), gradient: 0-60% acetonitrile in 85 min, flow rate 1
mL/min and absorbance at 280 nm.
Spring

Fall

Figure 7. RP-HPLC elution profile of Red maple crude proteins from Spring and Fall in 20 mM
Tris/HCl pH 8 buffer. Column: Vydac C18 (2.1x150mm), gradient: 0-60% acetonitrile in 85 min,
flow rate 1 mL/min and absorbance at 280 nm.
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3.4. Electrophoresis
The tris/tricine gels SDS-PAGE were successfully performed for the crude protein samples
extracted from Spring and Fall leaves as well as active (based on anticancer and anti-inflammatory
assays) gel filtration fraction F14. The SDS-PAGE electrophoresis which separates proteins based
on the molecular weight from high molecular weight to low molecular weight (from top to bottom).
The most frequently employed electrophoresis technique for proteins is Tris/tricine gels. Instead,
in our project, tris/tricine gels were preferred. This method of gel electrophoresis resolved the
small molecular weight proteins better than Tris/glycine gels. The electrophoretic profile observed
at different loading concentrations, in Fall leaves crude protein (Figure 8) and gel filtration
fraction F14 (Figure 9) several protein bands within a range of ~150-25 kDa, and relatively very
week bands from 25-5 kD range. However, the Spring leaves crude protein showed smeared bands
in the gels, as shown in Figure 8. The smearing observed while keeping all electrophoresis
conditions identical can not be answered at this time. It can be assumed that in Spring leaves
abundant proteins are expressed ranging from 37-20 kD, which overshadowed low abundant
proteins in the electrophoretic profile.
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S

S

S

S

S

S

F

F

F

Figure 8. Tris/tricine gel electrophoresis profile with reducing agent for the
Spring (S) and Fall (F) crude protein of Red maple in different
concentrations.
F14

Figure 9. Tris/tricine gel electrophoresis profile with reducing agent for the
Fall F14 FPLC fraction protein of Red maple.
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3.5. Proteomics of Maple Leaves
3.5.1. LC-MS/MS Q-TOF
Plant proteomics is a rapidly evolving field in the biochemistry with a focus on comparative or
differential protein expression profiling. In a proteomic evaluation of proteins, two main strategies
are in use known as top-down proteomics and bottom-up proteomics. The bottom-up proteomics
is most common and approaches for protein profiling studies where a limited quantity of crude
sample is available. Without going into exhaustive protein purification, peptides are generated
typically by enzymatic cleavage by trypsin and infused directly to electrospray LC/MS. The mass
spectrometric data than analyzed using bioinformatics tools. We successfully employed a bottomup proteomic approach using common LC/MS/MS mass spectrometric technique to characterize
the amino acid sequence from tryptic peptides of crude protein of Fall leaves. Due to the limited
quantity of Spring leaves protein, it was not proceeded further protein profiling. The
characterization of Fall leaves crude protein, and FPLC fraction F14 were achieved successfully.
The representative mass spectrometric profile of the fraction F14 LC/MS base peak chromatogram
(BPC) red in color, which show the most intense peaks at any one time in the mass spectra, while
the total ion chromatogram (TIC) green in color resulting from the summing up intensities of all
mass spectral peaks in the same scan as shown in Figure 10.
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BPC MS: Red
TIC MS/MS: Green

Figure 10. Tryptic digest profile of fraction F14 LC/MS profile of Fall leaves protein extracted
in FPLC. Column: Phenomenex BioZen 2.6 µm Peptide XB-C18 (pore size 100 Å, dimension
150×2.1), Mobile phase: A: 0.1% formic acid in water and solvent B: 0.1% formic acid in
acetonitrile at 0.3 mL/min flow rate, and gradient 0-55%B in 45 min.
3.5.2. Evaluation of MS/MS Data by Mascot
The mass spectrometric data is typically analyzed first by using search engine Mascot. It identifies
proteins from peptide databases (Perkins et al., 1999). Mascot uses a probabilistic scoring
algorithm adopted from the MOWSE (for MOlecular Weight SEarch) algorithm. The database
used was SwissProt, a manually annotated and reviewed database. We also used the NCBI nr (nonredundant) database, compiled by the National Center for Biotechnology Information (NCBI),
which contains non-redundant sequences from GenBank. The Mascot search engine used to
analyze the mass list obtained from LC-MS/MS data; a total of 25 proteins were identified in Fall
leaves crude protein extract by using the SwissProt database (Table 4). Identified proteins are from
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7 to 81 kDa. The highest score of 104 and the highest protein matches of 15 observed for protein
Ribulose bisphosphate.

The Fall leaves partially purified gel filtration fraction F14, two proteins identified are Chaperone
protein ClpC, chloroplastic (Pisum sativum) and protein Accelerated cell death-6 (ACD6) from
Arabidopsis thaliana by SwissProt database using the ID threshold score =27 (Table 5). The
Chaperone protein ClpC protein involved in the degradation of denatured proteins in the
chloroplast. The ACD6 is a novel ankyrin protein which is a dose-dependent activator of the
defense response against virulent pathogens, including bacteria, fungi, and oomycetes. The NCBI
nr database search revealed the identity of Phosphatidylinositol 3-/4-kinase (Macleaya cordata)
and unnamed protein from Coffea canephora using the ID threshold score =50 (Table 6). The
Phosphatidylinositol 3-/4-kinase is a signaling molecule in stomatal responses to environmental
signals. The highest protein Score 34 observed for Protein accelerated cell death-6 and by
SwissProt while the highest score of 56 for Phosphatidylinositol 3-/4-kinase (Macleaya cordata)
by NCBI nr.
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Table 4. Proteins in crude Fall leaves by Mascot search engine using SwissProt database. A total
of 25 proteins identified with a protein score above 44.
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Table 5. Proteins identified in Fall leaves gel filtration fraction F14 by Mascot search engine
using SwissProt database.

No.

Taxonomy

1

Pisum sativum

2

Arabidopsis
thaliana

Protein Description

Unique Peptide
Sequence

Chaperone protein ClpC,
chloroplastic Pisum sativum

Protein ACCELERATED CELL
DEATH 6 Arabidopsis thaliana

Protein Score

Peptide Expect

VSKAVSSRR

33

0.0044

SGLRAR

34

0.059

* ID threshold score = 27

Table 6. Proteins identified in Fall leaves gel filtration fraction F14 by Mascot search engine
using NCBI nr database.
No.

Taxonomy

1

Macleaya
cordata

2

Coffea
canephora

Protein Description
Phosphatidylinositol 3-/4-kinase
[Macleaya cordata]

unnamed protein product [Coffea
canephora]

Unique Peptide
Sequence

Protein Score

Peptide Expect

SAASLMAR

56

0.03

AAQVGLVSGK

50

0.039

* ID threshold score = 50
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3.5.3. MS/MS Data Search by De novo sequencing by PEAKS® software
The identification of proteins by mass spectrometry is dependent on the availability protein
sequences in mass spectrometry database. The classical Edman degradation technique is typically
utilized to establish the amino acid sequence. This technique is independent of the database to
identify the protein. The PEAKS® X is a new De novo peptide sequencing bioinformatics solution
for proteomics developed by Bioinformatics Solution Inc. It performs analysis and statistics
utilizing LC/MS/MS data using De novo sequencing and database search. A total of 54 proteins
were identified using PEAKS Studio- De novo sequencing database search from Fall maple leaves,
gel filtration fraction F14 as listed in Table 7. In this analysis, identified 54 proteins have at least
one unique peptide listed in the column as #Unique (Table 7). The statistically significant data
required to have a -logP (P˂0.05) values above 13. The analysis further revealed that four proteins
identified have at least two unique peptides -logP values above 25. The presence of at least two
unique peptides sequences found are highlighted in green color are from Cuscuta reflexa,
Arabidopsis thaliana, and Chlamydomonas reinhardtii (Table 7). The location and the amino acid
sequence of these peptides in the protein are shown in Figures 11, 12, and, 13, respectively.
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Table 7.|Proteins in Fall leaves gel filtration fraction F14 by De novo sequencing using PEAKS
Studio-X software. A total of 54 proteins identified.
Protein
ID
12646
8915
8863
6660
3263
3264
5210
33720
33722
33727
33732
33733
33741
33742
3427
7216
33759
33760
33761
33763
6755
9299
33771
33767

33768
5682
33776

Accession
O04979|LO
NP2_SPIOL
A2ZAI7|RO
C3_ORYSI
A2WY50|M
RS2F_ORY
SI
Q8GYU3|IY
O_ARATH
F4J7T2|EAF
1B_ARATH
F4J7T3|EAF
1A_ARATH
A9L9E2|TI2
14_LEMMI
Q9SJF1|LSG
12_ARATH
Q9C9W9|A
DO3_ARAT
H
B9GE13|KN
12F_ORYSJ
P0C587|HE
M1_ORYSJ
A2Z928|HE
M1_ORYSI
Q9FPP7|FA
C2B_CALO
F
Q7XL03|CL
PD2_ORYSJ
A7M9B2|TI
214_CUSRE
Q41382|RH7
_SPIOL
P43213|MP
AP1_PHLPR
Q8H7T4|EX
B10_ORYSJ
Q50EK5|C7
2B2_PINTA
Q43316|HE
M3_ARATH
Q32065|YC
X9_CHLRE
P10290|MY
BC_MAIZE
P58051|C71
BE_ARATH
Q9S7C0|HS
P7O_ARAT
H
F4HQD4|HS
P7P_ARAT
H
F4JSZ5|BIG
1_ARATH
Q9LVR3|U4
96G_ARAT
H

-10lgP

Coverage
(%)

#Unique

Avg. Mass

34.53

1

1

98272

Lon protease homolog 2, peroxisomal Spinacia oleracea

33.14

1

1

94725

Homeobox-leucine zipper protein Oryza sativa subsp. indica

32.12

3

1

48356

Magnesium transporter MRS2-F Oryza sativa subsp. indica

30.94

1

1

162425

30.08

1

2

206411

30.08

1

2

211665

29.91

1

1

228108

Protein TIC 214 Lemna minor

29.61

2

1

66743

GTPase LSG1-2 Arabidopsis thaliana

29.49

2

1

69063

Adagio protein 3 Arabidopsis thaliana

29.06

1

1

317312

Kinesin-like protein KIN-12F Oryza sativa subsp. japonica

28.32

2

1

58419

28.32

2

1

58435

27.3

2

1

43365

Fatty acid conjugase FAC2 Calendula officinalis

27.15

1

1

101483

Chaperone protein ClpD2, chloroplastic Oryza sativa subsp.
japonica

26.53

1

2

207375

Protein TIC 214 Cuscuta reflexa

25.71

2

1

73085

DEAD-box ATP-dependent RNA helicase 7 Spinacia oleracea

25.36

4

1

28457

Pollen allergen Phl p 1 Phleum pratense

25.36

4

1

28937

Expansin-B10 Oryza sativa subsp. japonica

25.34

2

1

56222

Cytochrome P450 720B2 Pinus taeda

25.29

2

1

41043

25.04

1

2

341667

24.99

5

1

28751

Anthocyanin regulatory C1 protein Zea mays

24.37

2

1

56900

Cytochrome P450 71B14 Arabidopsis thaliana

24.26

1

1

91750

Heat shock 70 kDa protein 14 Arabidopsis thaliana

24.26

1

1

91681

Heat shock 70 kDa protein 15 Arabidopsis thaliana

23.22

1

1

187536

Brefeldin A-inhibited guanine nucleotide-exchange protein 1
Arabidopsis thaliana

22.69

3

1

45597

UPF0496 protein At5g66670 Arabidopsis thaliana
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Identified Protein

Transcriptional elongation regulator MINIYO Arabidopsis
thaliana
Chromatin modification-related protein EAF1 B Arabidopsis
thaliana
Chromatin modification-related protein EAF1 A Arabidopsis
thaliana

Glutamyl-tRNA reductase, chloroplastic Oryza sativa subsp.
japonica
Glutamyl-tRNA reductase, chloroplastic Oryza sativa subsp.
indica

Porphobilinogen deaminase, chloroplastic OS=Arabidopsis
thaliana OX=3702 GN=HEMC PE=1 SV=1
Uncharacterized 341.7 kDa protein in psbD-psbC intergenic
region Chlamydomonas reinhardtii

EAF1A_ARATH and A
33777
33779
33704
33730

33793
2997
3218
3041
3038
3042
3040
3036
3037
3294
33794
33796
6733
33797
10085
8990
33800
33803
4099
33817
33783
33784
33785

O48881|TPS
1_BRANA
Q9SZH4|PE
P_ARATH
Q8H0T4|UP
L2_ARATH
Q8S2G5|GP
DH2_ORYS
J
Q9SXE1|GS
OX3_ARAT
H
Q14FG5|RP
OB_POPAL
Q2L8Z9|RP
OB_GOSHI
A4QLS5|RP
OB_NASOF
A4QKI4|RP
OB_CAPBU
P50546|RPO
B_ARATH
A4QKS3|RP
OB_CRUW
A
A4QJS5|RP
OB_OLIPU
A4QL11|RP
OB_DRANE
A4QLI6|RP
OB_LOBM
A
A4QJJ1|RPO
B_AETGR
Q9FEB5|DS
P4_ARATH
Q10PC5|TT
A1_ORYSJ
Q7EZD5|Y8
577_ORYSJ
F4JSV3|ED
A40_ARAT
H
F4JVN6|TPP
II_ARATH
P83181|POA
1_KALTU
A2ZVG7|FT
SH9_ORYSJ
A8J666|CFA
54_CHLRE
Q94BZ7|GY
RBM_ARA
TH
Q94H98|P2C
34_ORYSJ
P27759|PLY
5_AMBAR
Q6AVI8|CD
PK9_ORYSJ

Thiamine biosynthetic bifunctional enzyme BTH1, chloroplastic
Brassica napus
RNA-binding KH domain-containing protein PEPPER
Arabidopsis thaliana

22.61

2

1

56045

22.5

3

1

54025

22.41

0

1

403618

E3 ubiquitin-protein ligase UPL2 Arabidopsis thaliana

21.64

3

1

51584

Probable glycerol-3-phosphate dehydrogenase [NAD (+)] 2,
cytosolic Oryza sativa subsp. japonica

21.55

2

1

52688

Flavin-containing monooxygenase FMO GS-OX3 Arabidopsis
thaliana

21.38

1

1

120521

DNA-directed RNA polymerase subunit beta Populus alba

21.38

1

1

120559

DNA-directed RNA polymerase subunit beta Gossypium hirsutum

21.38

1

1

121076

21.38

1

1

121085

21.38

1

1

121059

DNA-directed RNA polymerase subunit beta Arabidopsis thaliana

21.38

1

1

120979

DNA-directed RNA polymerase subunit beta OS=Crucihimalaya
wallichii OX=78192 GN=rpoB PE=3 SV=1

21.38

1

1

120991

DNA-directed RNA polymerase subunit beta OS=Olimarabidopsis
pumila OX=74718 GN=rpoB PE=3 SV=1

21.38

1

1

120871

DNA-directed RNA polymerase subunit beta Draba nemorosa

21.38

1

1

121059

DNA-directed RNA polymerase subunit beta Lobularia maritima

21.38

1

1

120945

21.32

3

1

42626

21.15

2

1

78389

Protein TITANIA OS=Oryza sativa subsp. japonica

21.06

4

1

30720

Putative B3 domain-containing protein Oryza sativa subsp.
japonica

21.05

1

1

81479

Probable E3 ubiquitin-protein ligase EDA40 Arabidopsis thaliana

20.88

1

1

152367

Tripeptidyl-peptidase 2 Arabidopsis thaliana

20.87

21

1

4654

20.79

2

1

85793

20.71

1

1

317779

20.37

1

1

81053

DNA gyrase subunit B, mitochondrial Arabidopsis thaliana

22.27

3

1

41755

Probable protein phosphatase 2C 34 Oryza sativa subsp. japonica

22.26

4

1

42709

Pectate lyase 5 OS=Ambrosia artemisiifolia

22.25

2

1

63978

Calcium-dependent protein kinase 9 Oryza sativa subsp. japonica

34

DNA-directed RNA polymerase subunit beta Nasturtium
officinale
DNA-directed RNA polymerase subunit beta OS=Capsella bursapastoris OX=3719 GN=rpoB PE=3 SV=1

DNA-directed RNA polymerase subunit beta OS=Aethionema
grandiflorum
Phosphoglucan phosphatase DSP4, chloroplastic Arabidopsis
thaliana

Pollen allergen Sal k 1 (Fragments) Kali turgidum
ATP-dependent zinc metalloprotease FTSH 9,
chloroplastic/mitochondrial Oryza sativa subsp. japonica
Cilia- and flagella-associated protein 54 Chlamydomonas
reinhardtii

A7M9B2|TI214_CUSRE
Peptide
N.VHSPLFFDR.L
R.LSDSKKQNVPK.P

Uniq
Y
Y

-10lgP
19.03
15

Mass
1116.5715
1242.6931

Length
9
11

ppm
21.1
-47.4

Fraction
2
2

Scan
3880
6653

Source File
FML_F14_998.mzXML
FML_F14_998.mzXML

Start
682
1213

End
690
1223

total 2 peptides

Figure 11. Two unique peptides from fall leaves protein FPLC F14 matching to Cuscuta reflexa by
using De novo sequencing (PEAKS) software.

F4J7T3|EAF1A_ARATH
Peptide
K.VDGEPVVR.E
K.EDAILEEAR.I

Uniq
Y
Y

-10lgP
21.66
16.84

Mass
869.4606
1044.5087

Length
ppm
Fraction
8
-15.8
2
9
-27.8
2
total 2 peptides

Scan
5179
5977

Source File
FML_F14_998.mzXML
FML_F14_998.mzXML

Start
272
541

End
279
549

Figure 12. Two unique peptides from fall leaves protein FPLC F14 matching to Arabidopsis thaliana
by using De novo sequencing (PEAKS) software.
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Q32065|YCX9_CHLRE
Peptide

Uniq

-10lgP

Mass

K.SLNFALISHSK.K

Y

17.12

1215.6611

K.LNFSMVSLLDSK.M

Y

15.84

1352.7009

Length

ppm

Fraction

Scan

Start

End

11

-39

2

6754

FML_F14_998.mzXML

2444

2454

2

7308

FML_F14_998.mzXML

299

310

12
-1.1
total 2 peptides

Source File

Figure 13. Two unique peptides from fall leaves protein FPLC F14 matching to Chlamydomonas
reinhardtii by using De novo sequencing by PEAKS Studio-X software.

36

3.5.4. Gene Ontology Annotation
The gene ontology (GO) is a computational model of biological systems by GO Consortium
http://geneontology.org/. This tool provides a set of hierarchical vocabularies such as biological
process, molecular function, and cellular component https://www.uniprot.org/help/gene_ontology.
Based on GO annotation tool, the Fall leaves proteins are characterized in the category of
biological process 47% and 41% were involved in the cellular process and metabolic process,
respectively, as shown in Figure 14. Whereas, in cellular compartment categorization, most of the
proteins were found to be localized in chloroplast, membrane, and nucleus (34%, 21%, and 19%,
respectively) as in Figure 15. However, binding activity (48%), catalytic activity (36%), and
oxidoreductase activity (9%) were found in the category of molecular function, as in Figure 16.

Figure 14. Fall leaves protein extracts of Red maple based on biological process categorization
by using UniProt GO annotation.
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Figure 15. Fall leaves protein extracts of Red maple based on cellular compartment categorization
by using UniProt GO annotation.

Figure 16. Fall leaves protein extracts of Red maple based on molecular function categorization
by using UniProt GO annotation.
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3.6. Cytotoxic Evaluation of Protein Extracts
3.6.1. Protein Estimation
The Fall leaves protein extracted in 25 mM sodium phosphate buffer from gel filtration fraction
F14 was successfully estimated by using Bradford assay. The total protein was estimated as 250
µg/mL to prepare several protein concentrations for MTT assays.

3.6.2. MTT assays
The gel filtration chromatography peak fraction number 14 (F14) was screened at different doses
(4, 2, 1, 0.5, 0.25, 0.12, and 0.06 µg/mL) for their anti-proliferative effect on human breast cancer
cell lines (MCF-7 and MDA-MB-231). In a dose-dependent manner, F14 showed a potent
inhibitory effect in MCF-7 as well as MDA-MB-231 cell lines as illustrated in Figures 17 & 18.
In MCF-7 cell line, the growth and proliferation were inhibited by 92% at 4 µg/mL and 88% at 2
µg/mL concentration. Further, in MDA cell line, the F14 showed almost the same inhibitory effect
for the growth and proliferation by 90% at 4 µg/mL while 86% at 2 µg/mL concentration. The IC50
values were calculated for F14 in both experiments. In MCF-7, the IC50 value was 0.40 µg/mL ±
0.01 while in MDA-MB-231, the IC50 value was 0.43 µg/mL ± 0.02. These experiments revealed
that the fraction F14 was very potent against human breast cancer MCF-7 and MDA-MB-231 cell
lines even with low protein concentrations. Doxorubicin was used as a positive control in different
concentrations (0.6, 0.3, 0.15, 0.07, and 0.03 µg/mL) whereas untreated cells as a negative control
(Figure 19 and 20).
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Figure 17. Percentage of cell inhibition of MCF-7 human breast cancer cell line treated with
different concentrations of Fall leaves extracted protein from FPLC (F14) ranging from 0.06 to 4
µg/mL. Data expressed as a mean of triplicates ± SD for each dose.

Figure 1811. Percentage of cell inhibition of MDA-MB-231 human breast cancer cell line treated
with different concentrations of Fall leaves extracted protein from FPLC (F14) ranging from 0.06
to 4 µg/mL. Data expressed as a mean of triplicates ± SD for each dose.
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Figure 19. Percentage of cell inhibition of MCF-7 human breast cancer cell line treated with
different concentrations of doxorubicin ranging from 0.03 to 0.6 µg/mL. Data expressed as a mean
of triplicates ± SD for each dose.

Figure 20. Percentage of cell inhibition of MDA human breast cancer cell line treated with
different concentrations of doxorubicin ranging from 0.03 to 0.6 µg/mL. Data expressed as a mean
of triplicates ± SD for each dose.
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3.7 Anti-Inflammatory Evaluation of Protein Extracts
All crude extracted proteins from Spring and Fall leaves as well as gel filtration chromatography
fractions were successfully evaluated against RAW 264.7 Murine Macrophages cell line. The Fall
maple leaves crude protein extract, and gel filtration fractions F14 and F19 were active/ The Spring
maple leaves crude protein extract, and gel filtration pooled fraction (F11-13) and fraction F14
were active extracted proteins from Spring maple leaves as illustrated in Figure 21. The Fall leaves
gel filtration chromatography (F14), found to have significant activity in comparison to the
positive control (P<0.05) by decreasing nitric oxide production (Figure 22). These marked
differences observed could be due to the change in the expression of active proteins affected by
two different seasons.
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Fall

Spring

Figure 21. Activity Evaluation of extracted proteins from Red maple leaves against RAW 264.7
Murine Macrophages cell line by calculating NO production level.
.

Figure 22. Active and inactive extracted proteins from Red maple leaves using RAW 264.7
Murine Macrophages cell line.
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Chapter 4
CONCLUSION
This study has provided preliminary data on proteomics profile of red maple leaves using bottomup proteomics. Bioinformatics tools such as Mascot search engine based on LC/ MS/MS data
identified 34 proteins in fall leaves crude extract. De novo sequencing identified 54 proteins by
PEAKS software. GO Annotation, a computational model of biological systems further advanced
our knowledge about the proteins identified from Red maple leaves that grouped into three
categories involved in biological process, cellular compartment, and molecular functions. The
analysis of extracted proteins from Fall leaves crude and fraction (F14) in cell culture-based
bioassays revealed that Red maple has anti-cancer activity in MCF-7 and MDA-MB-231 human
breast cancer cell lines. Additionally, the extracted proteins (crude, fraction F14, and F19) from
Fall leaves as well as Spring leaves crude and fraction (F11-13 and F14) showed anti-inflammatory
activity against RAW 264.7 Murine Macrophages cell line. Future research to evaluate the
activities of purified peptides and their synthetic analogs could have a numerous impact to develop
anti-cancer and anti-inflammatory agents.
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